Brain scans reveal how experimental drug affects memory in schizophrenia
NCT ID NCT04457310
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 37 times
Summary
This study tested an experimental drug called CVL-562 in 112 people with early schizophrenia to see how it affects brain activity during memory tasks. Participants had five brain scans (fMRI) while doing a spatial memory exercise. The goal was to find brain markers that could help develop better treatments for memory and thinking problems in schizophrenia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY COURSE SCHIZOPHRENIA SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University
New York, New York, 10032, United States
-
Stony Brook University
Stony Brook, New York, 11794, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Yale University
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.